Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does USTEKINUMAB-STBA Cause Therapeutic response changed? 5 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapeutic response changed have been filed in association with USTEKINUMAB-STBA. This represents 2.7% of all adverse event reports for USTEKINUMAB-STBA.

5
Reports of Therapeutic response changed with USTEKINUMAB-STBA
2.7%
of all USTEKINUMAB-STBA reports
0
Deaths
0
Hospitalizations

How Dangerous Is Therapeutic response changed From USTEKINUMAB-STBA?

Of the 5 reports.

Is Therapeutic response changed Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB-STBA. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does USTEKINUMAB-STBA Cause?

Intentional product use issue (46) Off label use (43) Intentional dose omission (21) Crohn's disease (20) Death (15) Haematochezia (13) Condition aggravated (12) Diarrhoea (10) Colitis ulcerative (8) Psoriasis (8)

What Other Drugs Cause Therapeutic response changed?

TIRZEPATIDE (550) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (169) LEVOTHYROXINE (124) METHYLPHENIDATE (124) LAMOTRIGINE (111) LISDEXAMFETAMINE DIMESYLATE (104) BUPROPION (99) NAPROXEN (63) PREGABALIN (59) CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (55)

Which USTEKINUMAB-STBA Alternatives Have Lower Therapeutic response changed Risk?

USTEKINUMAB-STBA vs VADADUSTAT USTEKINUMAB-STBA vs VALACYCLOVIR USTEKINUMAB-STBA vs VALBENAZINE USTEKINUMAB-STBA vs VALBENAZINE DITOSYLATE USTEKINUMAB-STBA vs VALDECOXIB

Related Pages

USTEKINUMAB-STBA Full Profile All Therapeutic response changed Reports All Drugs Causing Therapeutic response changed USTEKINUMAB-STBA Demographics